ORIC — ORIC PHARMACEUTICALS INC

Ownership history in Caption Management, LLC  ·  10 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in ORIC PHARMACEUTICALS INC (ORIC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.11% (2025 Q2)
Avg. % of fund
0.02%
First filed
2023 Q2
Last filed
2025 Q3
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 49,389 -10,611 -17.7% 0.00% $593K $12.00
2025 Q3 REDUCED 60,000 -936,200 -94.0% 0.01% $720K $12.00
2025 Q2 ADDED 996,200 +861,200 +637.9% 0.11% $10.1M $10.15
2024 Q4 ADDED 135,000 +103,100 +323.2% 0.01% $1.1M $8.07
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ORIC price (monthly, adj. close)

Other funds also holding ORIC

As of 2025 Q4 — sorted by position size

Column Group LLC 3Y 34.98% PFIZER INC 18.6% SR ONE CAPITAL MANAGEMENT, LP 3Y 5.34% EcoR1 Capital, LLC 3Y 7Y 2.5% VR Adviser, LLC 3Y 2.29% Euclidean Capital LLC 3Y 2.19% First Turn Management, LLC 1.88% NEA Management Company, LLC 3Y 7Y 1.72% MPM BioImpact LLC 3Y 1.68% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.59%
← Back to Caption Management, LLC Holdings